Literature DB >> 18479102

Identification of the binding of sceptrin to MreB via a bidirectional affinity protocol.

Abimael D Rodríguez1, Martin J Lear, James J La Clair.   

Abstract

A bidirectional affinity system was used to screen for marine natural products that bound to Escherichia coli proteins. A system was developed and applied to isolate the natural product sceptrin from an Agelas conifera extract and its affinity partner MreB from E. coli lysate. The use of a dual immunoaffinity fluorescent (IAF) tag permitted this process to co-immunoprecipitate the bacterial equivalent of actin, MreB, from E. coli lysate. MreB was subsequently validated as a target for sceptrin using a resistance mapping approach. The combination of these studies suggests that natural products and their protein targets can be isolated in concert using a melody of forward and reverse affinity matrices. While the structure of sceptrin was elucidated by NMR analysis, the bulk of effort was conducted without knowing the structure of the natural product, thereby elevating a key bottleneck in the development of high-throughput methods for natural product discovery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18479102     DOI: 10.1021/ja7114019

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  17 in total

Review 1.  Natural products as chemical probes.

Authors:  Erin E Carlson
Journal:  ACS Chem Biol       Date:  2010-07-16       Impact factor: 5.100

2.  Pyrrole aminoimidazole alkaloid metabiosynthesis with marine sponges Agelas conifera and Stylissa caribica.

Authors:  E Paige Stout; Yong-Gang Wang; Daniel Romo; Tadeusz F Molinski
Journal:  Angew Chem Int Ed Engl       Date:  2012-04-04       Impact factor: 15.336

3.  Functional chromatography reveals three natural products that target the same protein with distinct mechanisms of action.

Authors:  Min Jin Kang; Tongde Wu; E M Kithsiri Wijeratne; Eric C Lau; Damian J Mason; Celestina Mesa; Joseph Tillotson; Donna D Zhang; A A Leslie Gunatilaka; James J La Clair; Eli Chapman
Journal:  Chembiochem       Date:  2014-08-14       Impact factor: 3.164

4.  Enantioselective total syntheses of (-)-palau'amine, (-)-axinellamines, and (-)-massadines.

Authors:  Ian B Seiple; Shun Su; Ian S Young; Akifumi Nakamura; Junichiro Yamaguchi; Lars Jørgensen; Rodrigo A Rodriguez; Daniel P O'Malley; Tanja Gaich; Matthias Köck; Phil S Baran
Journal:  J Am Chem Soc       Date:  2011-08-23       Impact factor: 15.419

5.  Aplysqualenol A binds to the light chain of dynein type 1 (DYNLL1).

Authors:  Brunilda Vera; Abimael D Rodríguez; James J La Clair
Journal:  Angew Chem Int Ed Engl       Date:  2011-07-08       Impact factor: 15.336

6.  MreB drives de novo rod morphogenesis in Caulobacter crescentus via remodeling of the cell wall.

Authors:  Constantin N Takacs; Sebastian Poggio; Godefroid Charbon; Mathieu Pucheault; Waldemar Vollmer; Christine Jacobs-Wagner
Journal:  J Bacteriol       Date:  2009-12-18       Impact factor: 3.490

7.  Chemical biology studies on norrisolide.

Authors:  Gianni Guizzunti; Thomas P Brady; Derek Fischer; Vivek Malhotra; Emmanuel A Theodorakis
Journal:  Bioorg Med Chem       Date:  2010-02-10       Impact factor: 3.641

Review 8.  Biosynthesis, asymmetric synthesis, and pharmacology, including cellular targets, of the pyrrole-2-aminoimidazole marine alkaloids.

Authors:  Ali Al-Mourabit; Manuel A Zancanella; Supriya Tilvi; Daniel Romo
Journal:  Nat Prod Rep       Date:  2011-05-09       Impact factor: 13.423

Review 9.  A submarine journey: the pyrrole-imidazole alkaloids.

Authors:  Barbara Forte; Beatrice Malgesini; Claudia Piutti; Francesca Quartieri; Alessandra Scolaro; Gianluca Papeo
Journal:  Mar Drugs       Date:  2009-11-27       Impact factor: 5.118

10.  Sceptrin, a marine natural compound, inhibits cell motility in a variety of cancer cell lines.

Authors:  Angel Cipres; Daniel P O'Malley; Ke Li; Darren Finlay; Phil S Baran; Kristiina Vuori
Journal:  ACS Chem Biol       Date:  2010-02-19       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.